Assessment Outcomes Histopathology of Ovarian Tumors
DOI:
https://doi.org/10.51699/ijhsms.v2i10.2668Keywords:
Ovarian tumors, benign tumor, malignant tumor, Mucinous, SerousAbstract
Background: Ovarian tumors account for 3% of all cancers and account for 25% of female genital tract-related malignancies.
Aim: This paper was focused on assessment outcomes related to related to patients who have undergone histopathology of Ovarian Tumors.
Patients and methods: The current cross-sectional study was enrolled patients with ovarian tumors to evaluate the outcomes of Histopathology of Ovarian Tumors. This study was conducted by modelling of present data that collected from different hospitals in Iraq between 17th May 2022 and 24th July 2023. The database was included patients with ages 25-60 years under BMI, which classify into (18.5-24.9), (25-29.9), (and 30-34.9). The data was processed to analysis tumor types and its effect on the survival rate of patients, where Comorbidities are considered one of the causes who effect on patients in the long term. Our results were analysed and designed by the SPSS program.
Results and discussion: the majority of patients was over 40 years old and had developed ovarian tumors, with smoking and obesity being identified as risk factors. Clinical outcomes showed that 87.8% of patients had a BMI of 29.9, whereas 12.2% were smokers. To further the outcomes, the study included various types of tumour detection. It was found that a Serous tumour was present in 50.0% of patients, Mucinous in 17.6%, and Fibroma in 12.2%. Additionally, the research discovered that 80% of patients had benign tumours, while 20% had malignant tumours. Patients with tumour sizes greater than or equal to 10 cm had a survival rate of 41.33%, while patients with tumour sizes between 8-10 cm had a rate of 29.33%.
Conclusions: Our study revealed that 80% of female patients had benign tumors while only 20% had malignant tumors. Additionally, our findings imply a decrease in patient survival rates over time.
Downloads
References
Manoja V, Pramood M, Jyothi V, Chandrashekar KP: Clinicopathological study of ovarian tumors: a 2-year study. Int J Sci Stud. 2017, 5:300-5.
Garg N, Anand AS, Annigeri C: Study of the histomorphological spectrum of ovarian tumours. Int J Med Health Res. 2017, 3:12-20.
Bandla S, Charan BV, Vissa S, Sai PV, Rao NM, Rao BS, Grandhi EB: Histopathological spectrum of ovarian tumors in a tertiary care hospital. Saudi J Pathol Microbiol. 2020, 5:50-5. 10.36348/sjpm. 2020.v05i02.002
Narang S, Singh A, Nema S, Karode R: Spectrum of ovarian tumours: a five-year study. J Pathol Nepal. 2017, 7:1180-3. 10.3126/jpn. v7i2.18002
Dutta A, Imran R, Saikia P, Borgohain M: Histopathological spectrum of ovarian neoplasms in a tertiary care hospital. Int J Contemp Med Res. 2018, 5:111-4. 10.21276/ijcmr.2018.5.8.2
Arora T, Mullangi S, Lekkala MR: Ovarian cancer. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022.
Shaik M, Divya S, Kadukuntla S, Annapoorna Y: Clinico-histopathological spectrum of ovarian tumors in tertiary care center Rajahmundry. Indian J Obstet Gynecol Res. 2022, 9:77-82. 10.18231/j.ijogr.2022.015
Khan MA, Afzal S, Saeed H, et al.: Frequency of ovarian tumors according to WHO histological classification and their association to age at diagnosis. Ann King Edw Med Univ. 2017, 10:23. 10.21649/akemu. v23i2.1579
Tejeswini V, Reddy S, Premalatha P, Vahini G: Study of morphological patterns of ovarian neoplasms. IOSR J Dent Med Sci. 2013, 10:11-6. 10.9790/0853-1061116
Goldblum JR, Lamps LW, McKenny JK, Myers JL: Rosai and Ackerman’s Surgical Pathology. Elsevier, Philadelphia, PA; 2018.
Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H: Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019, 11:287-99. 10.2147/IJWH.S197604
Yoneda A, Lendorf ME, Couchman JR, Multhaupt HA: Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans. J Histochem Cytochem. 2012, 60:9-21. 10.1369/0022155411428469
Singh S, Saxena V, Khatri SL, Gupta S, Garewal J, Dubey K: Histopathological evaluation of ovarian tumors. Imp J Interdiscipl Res. 2016, 2:435-9.
Modepalli N, Venugopal SB: Clinicopathological study of surface epithelial tumours of the ovary: an institutional study. J Clin Diagn Res. 2016, 10:EC01-4. 10.7860/JCDR/2016/21741.8716
Zaman S, Majid S, Hussain M, Chughtai O, Mahboob J, Chughtai S: A retrospective study of ovarian tumours and tumour-like lesions. J Ayub Med Coll Abbottabad. 2010, 22:104-8.
Sharma P, Rao PS, Mogra N, Talreja K: Histopathological study of ovarian tumours in a tertiary healthcare centre of southern Rajasthan. Indian J Pathol Oncol. 2020, 7:561-6. 10.18231/j.ijpo.2020.112
Tehranian A, Ghahghaei-Nezamabadi A, Seifollahi A, Kasraei S, Dehghani-Nejad H, Maleki-Hajiagha A: Ovarian mature cystic teratoma with malignant transformation: two case reports. J Med Case Rep. 2021, 15:23. 10.1186/s13256-020-02594-4
Dhende PD, Patil LY, Jashnani K: Spectrum of ovarian tumors in a tertiary care hospital. Indian J Pathol Oncol. 2021, 8:133-9. 10.18231/j.ijpo.2021.025
Bhagyalakshmi A, Sreelekha A, Sridevi S, Chandralekha J, Parvathi G, Venkatalakshmi A: Prospective study of histopathological patterns of ovarian tumours in a tertiary care centre. Int J Res Med Sci. 2014, 2:448-56. 10.5455/2320-6012.ijrms20140514
Thakkar NN, Shah SN: Histopathological study of ovarian lesions. Int J Sci Res. 2015, 4:1745-9.
Jain P, Malik R, Rampuri V: A 5-year retrospective study of ovarian tumours and tumour-like lesions in a tertiary referral centre, Gandhi Medical College, Bhopal. J Evol Med Dent Sci. 2020, 9:266-71. 10.14260/jemds/2020/60
